Liège, Belgium 1 October 2015, 17:45 – Mithra Pharmaceuticals today announces the strengthening of its management team with changes and appointments inside different departments: the appointment of Frederik Vanvoorden as Group Controller and Michael Truyen as new CLO. Eric Van Traelen, who has successfully assumed the role of CLO since 2006, will focus on his new function of Secretary of the Board and support the business development and M&A deals of the company. The Business Development structure will also be restructured and driven by a committee formed by the CEO, François Fornieri, and the CMO, Jan Van der Auwera.